Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Enjoy this offer
* See conditions under "Our services"

Valuation: Qiagen N.V.

Market Cap 7.81B 6.75B 6.22B 5.83B 10.89B 744B 11.09B 73.81B 28.64B 360B 29.31B 28.68B 1,251B P/E ratio 2026 *
18x
P/E ratio 2027 * 17.2x
Enterprise value 8.33B 7.21B 6.64B 6.22B 11.63B 795B 11.84B 78.79B 30.57B 384B 31.29B 30.61B 1,335B EV / Sales 2026 *
3.86x
EV / Sales 2027 * 3.61x
Free-Float
99.27%
Yield 2026 *
-
Yield 2027 * 0.5%
1 day+4.20%
1 week+5.77%
Current month+3.17%
1 month+14.26%
3 months-12.88%
6 months-21.29%
Current year-20.25%
1 week 36.23
Extreme 36.23
38.1
1 month 32.53
Extreme 32.53
38.1
Current year 32.53
Extreme 32.53
57.82
1 year 32.53
Extreme 32.53
57.82
3 years 32.53
Extreme 32.53
57.82
5 years 32.53
Extreme 32.53
64.74
10 years 23.11
Extreme 23.113
65.86
Manager TitleAgeSince
Chief Executive Officer 61 2019-10-06
Director of Finance/CFO 58 2003-12-31
Chief Operating Officer - 2022-03-31
Director TitleAgeSince
Director/Board Member 71 2003-12-31
Director/Board Member 77 2011-05-31
Director/Board Member 60 2021-01-07
Date Insider Type Main position Quantity % Market Cap.
25-10-22Sell

Chief Financial Officer

50,000 0.0230%
25-10-22Sell

Chief Financial Officer

18,577 0.0085%
25-10-22Sell

Chief Financial Officer

31,423 0.0144%
Change 5-day change 1-year change 3-year change Capi.($)
+4.20%+5.77%-22.33%-25.33% 7.81B
+0.09%+1.57%-13.87%-11.61% 43.4B
+0.71%-1.16%+268.53%+485.55% 31.79B
+1.39%+3.11%+20.82%-9.85% 31.09B
-0.97%-2.37%+1.66%+24.13% 29.81B
+6.65%-5.00%+11.42%+15.34% 24.46B
+1.17%+6.41%+11.76%+10.38% 13.19B
+1.94%+4.76%+56.47%+124.57% 13.33B
+3.61%-1.56% - - 13.24B
+1.41%+2.21%+102.88%+83.47% 12.33B
Average +2.02%+1.15%+48.60%+77.41% 22.05B
Weighted average by Cap. +1.56%+0.23%+52.67%+88.56%

Financials

2026 *2027 *
Net sales 2.16B 1.87B 1.72B 1.61B 3.01B 206B 3.06B 20.39B 7.91B 99.44B 8.1B 7.92B 346B 2.27B 1.97B 1.81B 1.7B 3.17B 217B 3.23B 21.49B 8.34B 105B 8.53B 8.35B 364B
Net income 406M 351M 323M 303M 566M 38.67B 576M 3.83B 1.49B 18.7B 1.52B 1.49B 64.99B 467M 404M 372M 349M 651M 44.5B 663M 4.41B 1.71B 21.52B 1.75B 1.71B 74.8B
Net Debt 526M 455M 419M 393M 734M 50.16B 747M 4.97B 1.93B 24.26B 1.98B 1.93B 84.31B 406M 351M 323M 303M 566M 38.67B 576M 3.83B 1.49B 18.7B 1.52B 1.49B 64.99B
Logo Qiagen N.V.
Qiagen NV is a holding company based in the Netherlands. The Company is engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Its Sample to Insight solutions integrate sample and assay technologies, bioinformatics and automation systems. Its sample technologies are used for isolating and preparing deoxyribonucleic acid (DNA), ribonucleic acid (RNA) and proteins from blood or other liquids, tissue, plants or other materials. Its assay technologies make these biomolecules visible for analysis, such as identifying the genetic information of a pathogen or a gene mutation in a tumor. Its bioinformatics solutions interpret data to provide actionable insights. The Company's automation platforms based on polymerase chain reaction (PCR), next-generation sequencing (NGS) and other technologies tie these together in molecular testing workflows from Sample to Insight.
Employees
5,500
Date Price Change Volume
26-06-09 37.75 $ +4.20% 2,159,381
26-06-08 36.23 $ -1.23% 1,485,840
26-06-05 36.68 $ -2.34% 1,412,867
26-06-04 37.56 $ +3.05% 2,865,864
26-06-03 36.45 $ +2.13% 3,248,219
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
37.75USD
Average target price
43.82USD
Spread / Average Target
+16.08%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. QGEN Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!